��ƷSM����ӰƬ

Activities led by Venture Partners at ��ƷSM����ӰƬ, the university’s commercialization arm, generated an economic impact of $8 billion nationally and $5.2 billion in the state of Colorado over the last five years.

Breathalyzer based on frequency comb spectroscopy quantum tech shows promise as a non-invasive diagnostic test for an array of diseases.

When pregnant moms breathe dirty air, it may adversely impact their baby’s brain, ��ƷSM����ӰƬ research suggests.

��ƷSM����ӰƬ’s International Genetically Engineered Machine team has developed a “magic soybean” that can churn out scarce pharmaceutical compounds while going easy on the environment.

Researchers building a budding life sciences startup leverage venture development programming to achieve a major funding milestone.

New international network explores how odors lead to actions.

Cheaper, faster test trades uncomfortable nose swab for spit-in-a-tube simplicity in effort to detect virus before it spreads

With antibiotic-resistant “superbugs” infecting 2 million people per year, and a dearth of new medications in the pipeline to treat them, ��ƷSM����ӰƬ researchers are taking a novel approach to addressing the looming public health crisis.

New shelf-stable vaccines could bolster lifesaving immunization deliveries worldwide.

Mounting evidence shows healthy resident bacteria can play a pivotal role in supporting physical health.